A multicenter, double-blind, randomized, parallel-group, active-controlled, phase 3 clinical trial to compare the effectiveness and safety of two botulinum toxin type A formulations for improving moderate to severe glabellar wrinkles in Asians-Reference-Cited by-同舟云学术

A multicenter, double-blind, randomized, parallel-group, active-controlled, phase 3 clinical trial to compare the effectiveness and safety of two botulinum toxin type A formulations for improving moderate to severe glabellar wrinkles in Asians

Published:2024-06-16 Issue:1 Volume:35 Page:
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Choi Sun Young¹^ORCID,Koh Young Gue²^ORCID,Lee Yang Won³⁴^ORCID,Son Hyung Seok³^ORCID,Yoon Yi Na³^ORCID,Kim Gyeonghoon⁵^ORCID,Won Chonghyun⁵^ORCID,Cho Hyesoo⁵^ORCID,Son Joo-Sun⁶^ORCID,Kim Eun-Kyoung⁶^ORCID,Kim Beom Joon²^ORCID

Affiliation:

1. Department of Dermatology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong-si, Gyeonggi-do, Republic of Korea

2. Department of Dermatology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea

3. Department of Dermatology, Konkuk University School of Medicine, Seoul, Republic of Korea

4. Research Institute of Medical Science, Konkuk University, Seoul, Republic of Korea

5. Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

6. R&D Center, BMI Korea

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2024.2359511

Reference14 articles.

1. Treatment of glabellar frown lines with C. botulinum-A exotoxin;Carruthers JD;Dermatol Surg Oncol,1992

2. Clinical Indications and Injection Technique for the Cosmetic Use of Botulinum A Exotoxin

3. Pharmacology of botulinum toxin

4. Efficacy and Safety of a Novel Botulinum Toxin Type A Product for the Treatment of Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Active-Controlled Multicenter Study

5. Arnon SS, Schechter R, Inglesby TV, et al. Botulinum toxin as a biological weapon: medical and public health management;JAMA,2001